Published on
02:45 GMT
Blocking SHOC2–RAS Interaction in RAS Cancers
In the relentless pursuit of conquering cancer, targeting the notorious family of RAS proteins remains a formidable challenge. RAS mutations, central to the oncogenic transformation in a wide spectrum of cancers, exhibit complex resistance mechanisms that …
Source:
Bioengineer.org
-
Pending
